Invigoratebio

India
Develops autologous T cell therapies, vaccines, and enzymes for cancer and health advancements.

About Invigoratebio

Invigoratebio is a Healthcare company based in India. It develops autologous T cell therapies, vaccines, and enzymes for cancer and health advancements. It operates on a B2B model. Invigoratebio offers products and services including Cell and Gene Therapy, Vaccines Technologies, and Recombinant Enzymes. Its focus areas include Biotechnology, Vaccines, Therapeutics and Cell and Gene Therapy. Its legal entity in India is Invigorate Biotechnologies LLP (ABZ-3530).

Company details

Invigorate Biotechnologies applies programming capabilities to create advanced autologous T cell therapies, targeting cancer patients with innovative cell and gene treatments. They specialize in research, process development, and commercial production of vaccines and recombinant enzymes. Based in India, the company collaborates with partners to advance biotechnologies, focusing on life-changing solutions while promoting teamwork and creativity in a dynamic environment.

Operational Areas

Products & Services of Invigoratebio

Invigoratebio offers a comprehensive portfolio of products and services, including Cell and Gene Therapy, Vaccines Technologies, and Recombinant Enzymes.

Cell and Gene Therapy
Therapeutics

Develops advanced therapies for cancer using cell techniques.

Vaccines Technologies
Vaccine Development

Provides expertise in vaccine research and production processes.

Recombinant Enzymes
Biotech Products

Creates enzymes for applications in health and biotechnology.

Board of directors of Invigorate Biotechnologies Llp (Invigoratebio)

Invigorate Biotechnologies Llp is the primary company behind Invigoratebio. The board of Invigorate Biotechnologies Llp currently have 2 directors; the longest-serving is Davender Kumar Bhati, appointed in 2022.

DirectorDesignationAppointedTenureEntity
Davender Kumar Bhati
DIN 07166234
Designated Partner07 Dec 20223 yrs 10 moInvigorate Biotechnologies Llp
Jainendra Jain
DIN 07166221
Designated Partner07 Dec 20223 yrs 10 moInvigorate Biotechnologies Llp
Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track β€” from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • βœ“
    Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • βœ“
    Full access to every database India & global coverage, advanced filters and rich profile details
  • βœ“
    Always-on access from your team account Single premium plan for everything you see on the portal

Frequently Asked Questions about Invigoratebio

Invigoratebio is headquartered in India.

Invigorate Biotechnologies applies programming capabilities to create advanced autologous T cell therapies, targeting cancer patients with innovative cell and gene treatments. They specialize in research, process development, and commercial production of vaccines and recombinant enzymes. Based in India, the company collaborates with partners to advance biotechnologies, focusing on life-changing solutions while promoting teamwork and creativity in a dynamic environment.

Invigoratebio offers Cell and Gene Therapy, Vaccines Technologies, and Recombinant Enzymes.

Invigoratebio operates through Invigorate Biotechnologies Llp.

The legal entities of Invigoratebio currently have 2 directors, including Davender Kumar Bhati, Jainendra Jain.

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available